Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial

Goerling, Ute; Gauler, Thomas; Dietz, Andreas; Gruenwald, Viktor; Knipping, Stephan; Guntinas-Lichius, Orlando; Frickhofen, Norbert; Lindeman, Hans-Walter; Fietkau, Rainer; Haxel, Boris; Grosse-Thie, Christina; Maschmeyer, Georg; Zipfel, Matthias; Martus, Peter; Knoedler, Maren; Keilholz, Ulrich; Klinghammer, Konrad

Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial

Autor(en):

Goerling, Ute; Gauler, Thomas; Dietz, Andreas; Gruenwald, Viktor; Knipping, Stephan; Guntinas-Lichius, Orlando; Frickhofen, Norbert; Lindeman, Hans-Walter; Fietkau, Rainer; Haxel, Boris; Grosse-Thie, Christina; Maschmeyer, Georg; Zipfel, Matthias; Martus, Peter; Knoedler, Maren; Keilholz, Ulrich; Klinghammer, Konrad

Tübinger Autor(en):

Martus, Peter

Erschienen in:

Oncology Research and Treatment (2022), Bd. 45, H. 6, S. 319-324

Verlagsangabe:

Karger

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1159/000521415

ISSN:

2296-5270